Company: STAA
Filing Date: 2025-10-20
Form Type: DFAN14A
Source: 0001213900-25-100410
Chunk: 3

Company: STAAR SURGICAL CO
Filing Date: 2025-10-20
Form: DFAN14A
Chunk 3
---
 Bailey, September 23, 2025)                                                                                   |

| ● | “[W]e believe the price of $28 per share significantly undervalues STAAR. Firstly, the $28 per share merger consideration              
 is discounted from the two previous offers from Alcon, the first of which was $58/share in April 2024 and the second was $55/share     
 + $7 contingent value in October 2024. Secondly, a discounted cash flow analysis undertaken by Broadwood, using the revised management 
 projections … and a WACC of 8.1% ... yields an equity value range of $22 to $49.66. If the initial management projections              
 (supplied to Alcon) are used, the result is an equity value reference range of $25.34 to $56.94.” (Egan-Jones, October                 
 10, 2025)                                                                                                                              |

Broadwood encourages its fellow shareholders to review the full statements
of these investors, which are available as resources at www.LetSTAARShine.com, along with Broadwood’s presentation, proxy materials,
and press releases. Broadwood continues to urges its fellow shareholders to vote “AGAINST” the proposed transaction
on the GREEN Proxy Card.

| 1 | Permission to use quote neither sought nor obtained. Emphasis 
 added.                                                        |

<div align='center'>Exhibit 1-3</div>

About Broadwood

Broadwood Partners, L.P. is managed by Broadwood Capital,
Inc. Broadwood Capital is a private investment firm based in New York City. Neal C. Bradsher is the President of Broadwood Capital.

Certain Information Concerning the Participants

Broadwood Partners, L.P., Broadwood Capital, Inc., Neal C. Bradsher,
Richard T. LeBuhn, Natalie R. Capasso, Raymond A. Myers and Jason J. Martin (collectively, the “Participants”) are participants
in the solicitation of proxies from the shareholders of STAAR in connection with the special meeting of shareholders scheduled for October
23, 2025 (including any adjournments, postponements, reschedulings or continuations thereof, the “Special Meeting”). The Participants
have filed a definitive proxy statement on Schedule 14A (the “Definitive Proxy Statement”) and accompanying GREEN Proxy
Card to be used in connection with any such solicitation of proxies from the Company’s shareholders for the Special Meeting. SHAREHOLDERS OF STAAR ARE URGED TO READ THESE MATERIAL